Polyrizon

Polyrizon EBITDA per Employee

The EBITDA per Employee of Polyrizon (PLRZ) as of Oct 21, 2026 is -5.95 M USD. In the previous year, EBITDA per Employee was -1.43 M USD — a change of 317.18% (lower).

EBITDA per Employee

-5.95 MUSD

YoY

317.18%

Last updated:

EBITDA per Employee of Polyrizon is 2025 -5.95 M USD. EBITDA per Employee of Polyrizon was 2024 -1.43 M USD. It decreases by 317.18% lower compared to the previous year.

The Polyrizon EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2020
-72,000.00 USD
Jan 1, 2021
-703,000.00 USD
Jan 1, 2022
-895,000.00 USD
Jan 1, 2023
-635,000.00 USD
Jan 1, 2024
-1.43 M USD
Jan 1, 2025
-5.95 M USD
The Polyrizon EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-5.95 MUSD+317.18%
-1.43 MUSD+124.57%
-635,000.00USD-29.05%
-895,000.00USD+27.31%
-703,000.00USD+876.39%
-72,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

EBITDA per Employee of Polyrizon is -5.95 M USD in 2025.

EBITDA per Employee of Polyrizon changed from -1.43 M USD to -5.95 M USD, representing a 317.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Polyrizon since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Polyrizon historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Polyrizon

All Key Metrics — Polyrizon